As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
Announcement: COVID-19 impact on peer review
Featured article: overcoming knowledge gaps on the burden of disease caused by meningococcal disease
Invasive meningococcal disease (IMB) occurs most commonly in children. There can be challenges in estimating the long term quality of life of IMD survivors.
In this study, researchers conducted a DELPHI questionnaire to identify knowledge gaps and to seek consensus on appropriate methods and study designs when investigating the burden caused by IMD.
Aims and scope
Health and Quality of Life Outcomes considers original manuscripts on the Health-Related Quality of Life (HRQOL) assessment for evaluation of medical and psychosocial interventions. It also considers approaches and studies on psychometric properties of HRQOL and patient reported outcome measures, including cultural validation of instruments if they provide information about the impact of interventions. The journal publishes study protocols and reviews summarising the present state of knowledge concerning a particular aspect of HRQOL and patient reported outcome measures. Reviews should generally follow systematic review methodology. Comments on articles and letters to the editor are welcome.
Sign up to receive article alerts
Health and Quality of Life Outcomes is published continuously online-only. We encourage you to sign up to receive free email alerts to keep up to date with all of the latest articles by registering here.
Mark Oremus, Editor-in-Chief
Dr Mark Oremus is an Associate Professor in the School of Public Health and Health Systems at the University of Waterloo, Canada. He holds a PhD in Epidemiology and Biostatistics from McGill University.
Dr Oremus' primary research interests include aging and chronic disease, cognition, dementia, and Alzheimer’s disease. He has conducted studies on willingness-to-pay for Alzheimer’s disease medications, measuring quality-of-life in Alzheimer’s disease, and the use of outcome measurement instruments in Alzheimer’s disease drug trials. His other research interests include systematic reviews, population and public health from a life-course perspective, health policy and economics, and knowledge transfer.
Annual Journal Metrics
136 days to first decision for reviewed manuscripts only
104 days to first decision for all manuscripts
251 days from submission to acceptance
15 days from acceptance to publication
866 Altmetric mentions